Ownership
Private
Employees
~40
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Small molecules

Axar Pharmaceuticals General Information

Axar Pharmaceuticals specializes in pharmaceutical R&D and development services, including formulation, process development, analytical services, packaging, regulatory strategy, clinical trials support, and intellectual property management. The company has demonstrated a track record of successful product launches and rapid NDA approvals for clients but does not publicly disclose its own clinical results or proprietary drug candidates.[2][9]

Contact Information

Primary Industry
Contract Manufacturing Organization
Corporate Office
Corona, California
United States

Drug Pipeline

No pipeline data available

For full access to Axar Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Axar Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Axar Pharmaceuticals's complete valuation and funding history, request access »

Axar Pharmaceuticals Financial Metrics